Government Support And Facility Upgrades Will Shape Future Biofuels Markets

The analyst price target for Archer-Daniels-Midland has been raised to $58.30, reflecting early stabilization in Nutrition, a more favorable Ag Services outlook, improved execution, and an expected Q2 EBITDA beat, partially offset by weaker North American crush margins. Analyst Commentary Early signs of stabilization in the Nutrition segment are emerging.

The analyst price target for Archer-Daniels-Midland has been raised to $55.00, primarily reflecting early stabilization in Nutrition, improved industry conditions and execution, and an expected Q2 EBITDA beat, partially offset by weaker North American crush margins. Analyst Commentary Early signs of stabilization in the Nutrition segment More constructive industry backdrop in Agricultural Services Improved company execution and increased policy visibility Expectation of Q2 EBITDA beating consensus by 6% Upside partially offset by anticipated weaker crush margins in North America Valuation Changes Summary of Valuation Changes for Archer-Daniels-Midland The Consensus Analyst Price Target has risen from $52.33 to $55.00.

AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to -0.0%.

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget has increased revenue growth from 1.0% to 2.8%.

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget has decreased revenue growth from -0.0% to 1.0%.